Thursday 15 February, 12-1pm, Seminar room 3, TRF - light lunch included.
Professor Eric Morand is Head of the School of Clinical Sciences at Monash Health, Monash University's largest clinical school. He is a specialist rheumatologist, and Head of the Monash Health Rheumatology Unit, the largest in Australia. He specalises in research and clinical care of systemic lupus erythematosus, as well as complex rheumatic diseases and rheumatoid arthriitis. He is founder of the Monash Lupus Clinic, Australia's largest Lupus-focused research-grounded clinic for patients with SLE, a founding member of the Australian Lupus Registry & Biobank, and Chair of the AsiaPaciifc Lupus Collaboration.
Dr Champa Nataraja presents “GILZ as a therapeutic target in Lupus”
Dr Champa Nataraja PhD student and Monash Health Rheumatology Fellow Dr Nataraja is the first recipient of the scholarship—her research aiming to improve outcomes for patients with lupus. Lupus is a chronic, multi-system autoimmune disease affecting at least 5 million people worldwide, with the majority being women of childbearing age. Over 70 per cent of patients with lupus are typically treated with glucocorticoids (GC) due to their broad anti-inflammatory effect, however, despite their effectiveness, the use of these drugs is accompanied by a litany of serious adverse effects that contribute to increased morbidity and mortality. Dr Nataraja is researching alternative therapies to GC that have similar anti-inflammatory effects but without the negative metabolic side-effects.